Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
191.82
+3.80 (2.02%)
At close: Feb 27, 2026, 4:00 PM EST
192.00
+0.18 (0.09%)
After-hours: Feb 27, 2026, 7:37 PM EST

Biogen Stock Forecast

Stock Price Forecast

The 25 analysts that cover Biogen stock have a consensus rating of "Buy" and an average price target of $194.72, which forecasts a 1.51% increase in the stock price over the next year. The lowest target is $115 and the highest is $255.

Price Target: $194.72 (+1.51%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$115$194.72$194$255
Change-40.05%+1.51%+1.14%+32.94%

Analyst Ratings

The average analyst rating for Biogen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingSep '25Oct '25Nov '25Dec '25Jan '26Feb '26
Strong Buy666658
Buy554454
Hold161413111314
Sell000111
Strong Sell000000
Total272523222427

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Hold
Initiates
$185
HoldInitiates$185-3.56%Feb 20, 2026
Wedbush
Wedbush
Hold
Maintains
$178$187
HoldMaintains$178$187-2.51%Feb 10, 2026
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$220$230
Strong BuyMaintains$220$230+19.90%Feb 9, 2026
BMO Capital
BMO Capital
Hold
Maintains
$165$196
HoldMaintains$165$196+2.18%Feb 9, 2026
Piper Sandler
Piper Sandler
Hold
Maintains
$157$177
HoldMaintains$157$177-7.73%Feb 9, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
9.62B
from 9.89B
Decreased by -2.70%
Revenue Next Year
9.53B
from 9.62B
Decreased by -0.95%
EPS This Year
15.21
from 8.79
Increased by 73.08%
EPS Next Year
16.06
from 15.21
Increased by 5.56%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
10.98B10.17B9.84B9.68B9.89B9.62B9.53B
Revenue Growth
-18.32%-7.36%-3.32%-1.62%2.22%-2.70%-0.95%
EPS
10.4020.877.9711.188.7915.2116.06
EPS Growth
-58.07%100.67%-61.81%40.28%-21.38%73.08%5.56%
Forward PE
-----12.6111.94
No. Analysts
-----3830
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
High10.4B10.7B
Avg9.6B9.5B
Low9.0B8.6B

Revenue Growth

Revenue Growth20262027202820292030
High
5.0%
10.8%
Avg
-2.7%
-0.9%
Low
-9.1%
-11.1%

EPS Forecast

EPS20262027202820292030
High17.9819.18
Avg15.2116.06
Low10.7912.28

EPS Growth

EPS Growth20262027202820292030
High
104.6%
26.1%
Avg
73.1%
5.6%
Low
22.8%
-19.3%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.